Delivery of small-interfering RNA (siRNA) to the brain
Open Access
- 5 February 2009
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 19 (2), 137-140
- https://doi.org/10.1517/13543770802680195
Abstract
Background: Two fundamental difficulties in the delivery of drugs to treat central nervous system (CNS) diseases are the systemic delivery of therapeutics across the bloodbrain-barrier (BBB), and the targeting of drugs to specific tissues or cells within the brain. With the advent and promise of RNA-based therapeutics that utilize RNA interference (RNAi) to trigger specific silencing of genes within diseased tissues, the necessity to surmount such obstacles has become even more urgent. Objective: Most pre-clinical and clinical studies on delivery of RNAi to the CNS have utilized invasive, intra-cerebral delivery of RNA to the targeted tissue. Thus, methods need to be developed to facilitate delivery of therapeutically significant quantities of RNA to the CNS via the systemic route, and to elicit clinically significant RNAi effects within the CNS tissues. Methods: Cell-penetrating-peptides (CPPs) are ‘molecular delivery vehicles’ that can traverse cell membranes and co-transport peptides or polynucleotides. The present invention examines 1) the utility of CPP-RNA duplexes for delivery of RNA to CNS tissues and, 2) cell-mediated release of the RNA payload once the CPP-RNA duplex is internalized by the CNS cells. Conclusions: The invention and embodiments listed therein outline molecular tools that can be adapted for non-invasive, systemic delivery of therapeutic RNA to the CNS in a future clinical setting.Keywords
This publication has 28 references indexed in Scilit:
- Nonviral delivery of synthetic siRNAs in vivoJCI Insight, 2007
- Targeting neurological disease with RNAiMolecular BioSystems, 2007
- Transvascular delivery of small interfering RNA to the central nervous systemNature, 2007
- MicroRNA and Brain Tumors: A Cause and a Cure?DNA and Cell Biology, 2007
- shRNA and siRNA delivery to the brainAdvanced Drug Delivery Reviews, 2007
- Strategies for silencing human disease using RNA interferenceNature Reviews Genetics, 2007
- Intravenous RNA Interference Gene Therapy Targeting the Human Epidermal Growth Factor Receptor Prolongs Survival in Intracranial Brain CancerClinical Cancer Research, 2004
- Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cellsFEBS Letters, 2004
- In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult ratsThe Journal of Gene Medicine, 2003
- A System for Stable Expression of Short Interfering RNAs in Mammalian CellsScience, 2002